Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q3 2023 ▲▼ | Q4 2023 ▲▼ | Change ▲▼ | Q3 2023 ▲▼ | Q4 2023 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Immunogen Inc | 0 | 1,404,608 | +1,404,608 | $0 | $41.65M | 8.30% | +$41.65M |
| Cerevel Therapeutics Hldng I | 685,061 | 750,000 | +64,939 | $14.95M | $31.80M | 6.34% | +$16.85M |
| Cymabay Therapeutics Inc | 1,129,376 | 1,090,441 | -38,935 | $16.84M | $25.76M | 5.14% | +$8.92M |
| Madrigal Pharmaceuticals, Inc.(MDGL) | 85,000 | 100,000 | +15,000 | $12.41M | $23.14M | 4.61% | +$10.72M |
| Xenon Pharmaceuticals Inc.(XENE) | 300,438 | 460,000 | +159,562 | $10.26M | $21.19M | 4.22% | +$10.92M |
| BridgeBio Pharma, Inc.NOTE 2 500 3 1(BBIO) | 0 | 0 | 0 | $16.41M | $20.58M | 4.10% | +$4.17M |
| Teva Pharmaceutical Industries LimitedADS(TEVA) | 2,000,000 | 1,900,000 | -100,000 | $20.40M | $19.84M | 3.95% | -$564.0K |
| Arcellx Inc COMMON STOCK | 400,000 | 340,000 | -60,000 | $14.35M | $18.87M | 3.76% | +$4.52M |
| LianMedicalADS(LIANY) | 672,357 | 3,779,694 | +3,107,337 | $1.00M | $16.90M | 3.37% | +$15.89M |
| Crinetics Pharmaceuticals In | 450,000 | 447,095 | -2,905 | $13.38M | $15.91M | 3.17% | +$2.52M |
| Celldex Therapeutics, Inc.(CLDX) | 150,000 | 400,000 | +250,000 | $4.13M | $15.86M | 3.16% | +$11.74M |
| Apogee Therapeutics Inc | 1,045,110 | 537,093 | -508,017 | $22.26M | $15.01M | 2.99% | -$7.25M |
| Immunovant, Inc.(IMVT) | 300,000 | 345,000 | +45,000 | $11.52M | $14.53M | 2.90% | +$3.02M |
| Cytokinetics, Incorporated(CYTK) | 230,366 | 160,000 | -70,366 | $6.79M | $13.36M | 2.66% | +$6.57M |
| Nuvalent Inc | 50,000 | 175,000 | +125,000 | $2.30M | $12.88M | 2.57% | +$10.58M |
| Astria Therapeutics Inc | 1,000,300 | 1,466,465 | +466,165 | $7.46M | $11.26M | 2.25% | +$3.80M |
| Verona Pharma PlcADS | 368,329 | 563,824 | +195,495 | $6.00M | $11.21M | 2.23% | +$5.21M |
| Spyre Therapeutics, Inc.(SYRE) | 242,297 | 517,554 | +275,257 | $2.97M | $11.14M | 2.22% | +$8.17M |
| Autolus Therapeutics plcADS(AUTL) | 1,992,466 | 1,550,408 | -442,058 | $4.64M | $9.98M | 1.99% | +$5.34M |
| Alkermes plcSHS(ALKS) | 100,000 | 356,384 | +256,384 | $2.80M | $9.89M | 1.97% | +$7.09M |
| Inozyme Pharma Inc | 1,379,852 | 1,885,802 | +505,950 | $5.80M | $8.03M | 1.60% | +$2.24M |
| Nurix Therapeutics, Inc.(NRIX) | 250,000 | 690,112 | +440,112 | $1.97M | $7.12M | 1.42% | +$5.16M |
| Centessa Pharmaceuticals PlcADS | 1,018,091 | 795,729 | -222,362 | $6.59M | $6.33M | 1.26% | -$253.0K |
| Establishment Labs Holdings Inc.(ESTA) | 239,108 | 228,277 | -10,831 | $11.73M | $5.91M | 1.18% | -$5.82M |
| Mirati Therapeutics Inc | 60,426 | 100,049 | +39,623 | $2.63M | $5.88M | 1.17% | +$3.25M |
| Roivant Sciences Ltd.SHS(ROIV) | 150,000 | 500,000 | +350,000 | $1.75M | $5.62M | 1.12% | +$3.86M |
| Viking Therapeutics, Inc.(VKTX) | 300,000 | 300,000 | 0 | $3.32M | $5.58M | 1.11% | +$2.26M |
| Savara Inc.(SVRA) | 1,150,000 | 1,150,000 | 0 | $4.35M | $5.41M | 1.08% | +$1.06M |
| COMPASS Pathways plcADS(CMPS) | 0 | 550,000 | +550,000 | $0 | $4.81M | 0.96% | +$4.81M |
| Apellis Pharmaceuticals Inc COM | 40,000 | 75,000 | +35,000 | $1.52M | $4.49M | 0.90% | +$2.97M |
| MoonLake ImmunotherapeuticsCL A(MLTX) | 50,000 | 70,988 | +20,988 | $2.85M | $4.29M | 0.85% | +$1.44M |
| Dynavax Technologies Corp | 200,000 | 300,000 | +100,000 | $2.95M | $4.19M | 0.84% | +$1.24M |
| AstraZeneca PLCADR(AZN) | 60,000 | 60,000 | 0 | $4.06M | $4.04M | 0.81% | -$22.2K |
| Axsome Therapeutics, Inc.(AXSM) | 0 | 50,000 | +50,000 | $0 | $3.98M | 0.79% | +$3.98M |
| Springworks Therapeutics Inc | 41,581 | 100,000 | +58,419 | $961.4K | $3.65M | 0.73% | +$2.69M |
| Omeros CorpNOTE 5 250 2 1 | 0 | 0 | 0 | $0 | $3.60M | 0.72% | +$3.60M |
| Coherus Oncology, Inc.NOTE 1 500 4 1(CHRS) | 0 | 0 | 0 | $0 | $3.40M | 0.68% | +$3.40M |
| Relay Therapeutics, Inc.(RLAY) | 0 | 300,000 | +300,000 | $0 | $3.30M | 0.66% | +$3.30M |
| BridgeBio Pharma, Inc.(BBIO) | 30,000 | 80,000 | +50,000 | $791.1K | $3.23M | 0.64% | +$2.44M |
| Krystal Biotech, Inc.(KRYS) | 57,500 | 25,000 | -32,500 | $6.67M | $3.10M | 0.62% | -$3.57M |
| Cullinan Therapeutics, Inc.(CGEM) | 0 | 300,000 | +300,000 | $0 | $3.06M | 0.61% | +$3.06M |
| Tango Therapeutics, Inc.(TNGX) | 350,000 | 300,274 | -49,726 | $3.94M | $2.97M | 0.59% | -$968.3K |
| argenx SEADR(ARGX) | 0 | 7,500 | +7,500 | $0 | $2.85M | 0.57% | +$2.85M |
| Kura Oncology, Inc.(KURA) | 856,535 | 191,535 | -665,000 | $7.81M | $2.75M | 0.55% | -$5.06M |
| EyePoint, Inc.(EYPT) | 0 | 109,900 | +109,900 | $0 | $2.54M | 0.51% | +$2.54M |
| Ascendis Pharma A/SADR(ASND) | 46,400 | 20,000 | -26,400 | $4.34M | $2.52M | 0.50% | -$1.83M |
| Mersana Therapeutics Inc | 2,850,000 | 1,000,000 | -1,850,000 | $3.62M | $2.32M | 0.46% | -$1.30M |
| Immatics N.V.SHS(IMTX) | 200,000 | 200,000 | 0 | $2.32M | $2.11M | 0.42% | -$210.0K |
| Penumbra, Inc.(PEN) | 0 | 7,500 | +7,500 | $0 | $1.89M | 0.38% | +$1.89M |
| Tourmaline Bio Inc | 0 | 68,081 | +68,081 | $0 | $1.78M | 0.36% | +$1.78M |
| ADC Therapeutics SASHS(ADCT) | 1,100,000 | 1,013,540 | -86,460 | $986.7K | $1.68M | 0.34% | +$695.8K |
| Vaxcyte, Inc.(PCVX) | 25,000 | 25,000 | 0 | $1.27M | $1.57M | 0.31% | +$295.5K |
| Kalvista Pharmaceuticals Inc | 278,292 | 125,969 | -152,323 | $2.68M | $1.54M | 0.31% | -$1.14M |
| Mirum Pharmaceuticals, Inc.(MIRM) | 30,000 | 50,000 | +20,000 | $948.0K | $1.48M | 0.29% | +$528.0K |
| Newamsterdam Pharma Company ORDINARY SHARES | 125,000 | 125,000 | 0 | $1.16M | $1.40M | 0.28% | +$240.0K |
| Neurocrine Biosciences, Inc.(NBIX) | 0 | 10,000 | +10,000 | $0 | $1.32M | 0.26% | +$1.32M |
| Inari Med Inc | 0 | 20,000 | +20,000 | $0 | $1.30M | 0.26% | +$1.30M |
| Allogene Therapeutics Inc | 0 | 400,000 | +400,000 | $0 | $1.28M | 0.26% | +$1.28M |
| Morphic Hldg Inc | 270,000 | 42,670 | -227,330 | $6.19M | $1.23M | 0.25% | -$4.95M |
| Viridian Therapeutics, Inc.(VRDN) | 0 | 50,000 | +50,000 | $0 | $1.09M | 0.22% | +$1.09M |
| Biohaven Ltd.(BHVN) | 30,156 | 20,866 | -9,290 | $784.4K | $893.1K | 0.18% | +$108.7K |
| Puma Biotechnology, Inc.(PBYI) | 202,349 | 202,349 | 0 | $532.2K | $876.2K | 0.17% | +$344.0K |
| Fulcrum Therapeutics, Inc.(FULC) | 0 | 125,000 | +125,000 | $0 | $843.8K | 0.17% | +$843.8K |
| Avrobio Inc | 500,000 | 500,000 | 0 | $770.0K | $680.0K | 0.14% | -$90.0K |
| Immatics N.VW EXP 07 01 202 | 187,204 | 187,204 | 0 | $662.7K | $546.6K | 0.11% | -$116.1K |
| Newamsterdam Pharma CompanyW EXP 11 22 202 *W EXP 99/99/999 | 137,000 | 137,000 | 0 | $260.3K | $428.8K | 0.09% | +$168.5K |
| Terns Pharmaceuticals Inc | 325,000 | 66,000 | -259,000 | $1.63M | $428.3K | 0.09% | -$1.21M |
| Nuvation Bio Inc.CL A(NUVB) | 250,000 | 250,000 | 0 | $335.0K | $377.5K | 0.08% | +$42.5K |
| Context Therapeutics Inc.(CNTX) | 328,817 | 328,817 | 0 | $496.5K | $371.6K | 0.07% | -$125.0K |
| InflaRx N.V.(IFRX) | 325,097 | 200,097 | -125,000 | $968.8K | $326.2K | 0.07% | -$642.6K |
| Promis Neurosciences Inc | 265,958 | 265,958 | 0 | $526.7K | $305.9K | 0.06% | -$220.8K |
| Aravive Inc | 346,511 | 346,511 | 0 | $45.7K | $42.9K | 0.01% | -$2.9K |
| Rocket Pharmaceuticals, Inc.W EXP 09 02 202(RCKT) | 75,000 | 75,000 | 0 | $7.5K | $36.8K | 0.01% | +$29.3K |
| ALDEYRA THERAPEUTICS INCCOM(ALDX) | 44,348 | 0 | -44,348 | $296.2K | $0 | — | -$296.2K |
| BIOATLA INCCOM(BCAB) | 180,000 | 0 | -180,000 | $306.0K | $0 | — | -$306.0K |
| INSPIRE MED SYS INCCOM(INSP) | 6,293 | 0 | -6,293 | $1.25M | $0 | — | -$1.25M |
| INSULET CORPCOM(PODD) | 5,000 | 0 | -5,000 | $797.5K | $0 | — | -$797.5K |
| LANTHEUS HLDGS INCCOM(LNTH) | 30,000 | 0 | -30,000 | $2.08M | $0 | — | -$2.08M |
| MILESTONE PHARMACEUTICALS INCOM(MIST) | 335,068 | 0 | -335,068 | $1.04M | $0 | — | -$1.04M |
| NLS PHARMACEUTICS LTDSHS | 200,455 | 0 | -200,455 | $140.3K | $0 | — | -$140.3K |
| PROTHENA CORP PLCSHS SHS | 79,214 | 0 | -79,214 | $3.82M | $0 | — | -$3.82M |
| SEAGEN INCCOM | 10,000 | 0 | -10,000 | $2.12M | $0 | — | -$2.12M |
| TALARIS THERAPEUTICS INCCOM | 400,000 | 0 | -400,000 | $1.12M | $0 | — | -$1.12M |
| THESEUS PHARMACEUTICALS INCCOM | 400,726 | 0 | -400,726 | $1.08M | $0 | — | -$1.08M |
| TRAVERE THERAPEUTICS INCCOM(TVTX) | 100,000 | 0 | -100,000 | $894.0K | $0 | — | -$894.0K |